Stock · Healthcare
SYK Stryker Corporation
Stryker Corporation has a solid dividend profile with no major red flags in the snapshot data.
Why we rate it 7.6
- Low yield of 1.07% — typical of growth-tilted stocks
- Payout ratio of 40% is comfortable — typical for mature dividend payers
- Current yield is in line with the 5-year average of 0.99%
- Large-cap scale (>$50B) — established business with predictable cash flows
Where SYK ranks
We compute the same 0–10 safety score across 53 dividend-paying stocks and ETFs. Here's where SYK lands inside that universe.
The universe is curated to the most-searched US dividend payers. We'll expand it as the data layer grows; sector percentiles only appear when we have at least 5 comparable peers.
The two questions a safety score doesn't answer
A safety score tells you how durable SYK's payout looks. It does not tell you what you keep after tax, or whether something else does the same job better.
On tax: what you actually pocket depends on whether SYK dividends are qualified — qualified distributions are taxed at 0%, 15%, or 20%, while ordinary ones are taxed at your full marginal rate, a gap that can reach 22 percentage points of the income on the same headline yield.
On substitutes: if SYK's 7.6/10 score is lower than you want, see SYK alternatives — same-sector stocks ranked by how closely they match SYK on both yield and safety, so you can see what a swap actually costs you.
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
How we score dividend safety
The Infnits dividend safety score is a 0–10 rating derived from yield zone, payout ratio (when applicable), yield trend versus 5-year average, instrument type, and company size. Each factor is independently transparent — see the reasons above for exactly which factors contributed to SYK's score.
For the full methodology including the in-app version that uses ETF look-through and historical cut data, see our methodology page.
This is educational, not investment advice. Dividend safety scores reflect a snapshot of public data on the "as of" date shown. Verify current data on the issuer's investor relations page or your brokerage before making decisions.
Frequently asked questions
Is SYK safe?
On dividend safety specifically, Infnits scores SYK 7.6/10 — solid. Stryker Corporation has a solid dividend profile with no major red flags in the snapshot data. That score measures how durable the payout looks based on yield zone, payout ratio, yield trend, and instrument type; it does not measure price risk, valuation, or whether SYK suits your portfolio.
Is SYK's dividend safe?
Based on snapshot data — yield 1.07%, payout ratio 40%, instrument type stock — Infnits rates SYK's dividend safety profile as solid (7.6/10). This is one signal, not a recommendation.
What is SYK's current dividend yield?
SYK has a current dividend yield of 1.07% as of April 28, 2026. Its 5-year average yield is 0.99%.
How is SYK's safety score calculated?
The score combines yield zone (yields above 7% historically carry elevated cut risk), payout ratio (lower is safer), trend vs. 5-year average yield, instrument type (ETFs are inherently more diversified), and size (larger companies have more stable cash flows). Each factor is scored 0-2.5 and summed to a 0-10 result.
Where does this data come from?
Fundamentals are sourced from public market data and refreshed regularly. The "as of" date on each page reflects the snapshot used for the score. For real-time data, check the issuer's investor relations page or your brokerage.
Should I buy SYK based on this score?
No — this is an educational score based on a handful of public signals, not investment advice. Use it as one input among many. For a portfolio-aware analysis with ETF look-through and personalized insights, install the Infnits app.
Get emailed when SYK score changes.
More SYK analysis
Other dividend tickers
See how SYK fits your portfolio
Add your other holdings and the free analyzer shows your total annual income, weighted safety score, and whether SYK is carrying too much of your income. Runs in your browser — no account, no download.
Or read how safety scoring works.